Blog
RSS FeedPosted by Michael Wonder on 22 Mar 2021
ATAGI statement and clinical guidance on AstraZeneca COVID-19 vaccine following EMA safety review
19 March 2021 - This statement from the Australian Technical Advisory Group on Immunisation updates advice previous provided on 16 March. ...
Posted by Michael Wonder on 21 Mar 2021
TGA approves CSL - Seqirus to manufacture AstraZeneca COVID-19 vaccine in Australia
21 March 2021 - Earlier today, the Therapeutic Goods Administration approved manufacture of the AstraZeneca COVID-19 Vaccine (ChAdOx1-S) in Australia. ...
Posted by Michael Wonder on 21 Mar 2021
AstraZeneca vaccine allowed by government regulators to be produced in Australia
21 March 2021 - Astra Zeneca vaccines will be produced in Australia from now on after the regulators approved doses being ...
Posted by Michael Wonder on 18 Mar 2021
AstraZeneca ChAdOx1-S COVID-19
18 March 2021 - The TGA is closely reviewing reports of anaphylaxis after four cases were reported following the AstraZeneca ChAdOx1-S ...
Posted by Michael Wonder on 16 Mar 2021
ATAGI statement in response to European decisions about the AstraZeneca vaccine
16 March 2021 - ATAGI notes the suspension of the AstraZeneca vaccine program in several European countries due to reports ...
Posted by Michael Wonder on 16 Mar 2021
Doctors complain of ‘gag’ over AstraZeneca vaccine
16 March 2021 - High-profile doctors have complained they are being gagged from speaking out about their concerns on the ...
Posted by Michael Wonder on 14 Mar 2021
Approval of updated storage conditions for the Pfizer COVID-19 vaccine
13 March 2021 - The TGA has received and assessed additional data submitted by Pfizer for their COVID-19 vaccine (COMIRNATY - ...
Posted by Michael Wonder on 13 Mar 2021
COVID-19 vaccines - safety and effectiveness in older adults
10 March 2021 - Data on real-world use of COVID-19 vaccines approved in Australia provides reassurance about their safety in ...
Posted by Michael Wonder on 05 Mar 2021
TGA adopts Access Consortium guidance for fast-tracking authorisations of modified COVID-19 vaccines for variant
5 March 2021 - TGA has adopted guidance developed by the Access Consortium - a coalition of regulatory authorities from ...
Posted by Michael Wonder on 23 Feb 2021
TGA bans Pfizer, AstraZeneca brand mentions in COVID-19 vaccine advertising
24 February 2021 - Pharmacies, GPs and healthcare organisations will be banned from displaying advertisements identifying whether they are using ...
Posted by Michael Wonder on 16 Feb 2021
Medicines Australia statement on TGA’s provisional approval of AstraZeneca’s COVID-19 vaccine
16 February 2021 - Medicines Australia welcomes the TGA’s decision granting provisional approval of the AstraZeneca/Oxford University COVID-19 vaccine, marking ...
Posted by Michael Wonder on 16 Feb 2021
TGA provisionally approves AstraZeneca's COVID-19 vaccine
16 February 2021 - The Therapeutic Goods Administration has granted provisional approval to AstraZeneca for its COVID-19 vaccine, making it ...
Posted by Michael Wonder on 15 Feb 2021
One billion dollar bid to go it alone with COVID-19 vaccine hub
15 February 2021 - A proposal for a state-of-the-art $1 billion facility to manufacture vaccines and prescription drugs in Australia ...
Posted by Michael Wonder on 11 Feb 2021
COVID-19 vaccine shipment could arrive in Australia as early as next week
11 February 2021 - Coronavirus vaccines are a step closer to arriving in Australia after the European Commission formally approved ...
Posted by Michael Wonder on 11 Feb 2021
CSL confident it can make vaccine to cover variants, if needed
11 February 2021 - CSL is confident it can make an updated version of AstraZeneca’s COVID-19 vaccine to cover any ...